Michael Weig
Impact in
- Infectious Diseases top 1%
- Antifungal resistance and susceptibility
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antifungal resistance and susceptibility 38
- SARS-CoV-2 detection and testing 2
-
- Bacterial Identification and Susceptibility Testing 11
- Co-authors
- Oliver Bader (40 shared papers)Uwe Groß (46 shared papers)Piet W. J. de Groot (9 shared papers)Raimond Lugert (10 shared papers)Albert D. de Boer (5 shared papers)Martin Kuhns (5 shared papers)Diane E Kelly (4 shared papers)Andrew G. S. Warrilow (4 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (7 papers)Mycoses (5 papers)PLoS ONE (5 papers)Journal of Clinical Microbiology (4 papers)Journal of Antimicrobial Chemotherapy (3 papers)
- Partner nations
- GermanyUnited KingdomNetherlands
In The Last Decade
Michael Weig
72 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 90
- Infectious Diseases 1.7k
- Clinical Biochemistry 288
- Molecular Medicine 81
- Molecular Biology 665
- Epidemiology 274
Countries citing papers authored by Michael Weig
This map shows the geographic impact of Michael Weig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Weig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Weig more than expected).
Fields of papers citing papers by Michael Weig
This network shows the impact of papers produced by Michael Weig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Weig. The network helps show where Michael Weig may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Weig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 264 | |
| 2 | 2008 | 207 | |
| 3 | 2010 | 194 | |
| 4 | 2010 | 149 | |
| 5 | 2010 | 143 | |
| 6 | 2013 | 120 | |
| 7 | 2012 | 97 | |
| 8 | 2017 | 94 | |
| 9 | 2007 | 90 | |
| 10 | 2015 | 89 | |
| 11 | 2004 | 84 | |
| 12 | 2012 | 84 | |
| 13 | 2012 | 78 | |
| 14 | 2020 | 69 | |
| 15 | 2007 | 55 | |
| 16 | 1995 | 53 | |
| 17 | 1998 | 52 | |
| 18 | 2001 | 51 | |
| 19 | 2002 | 48 | |
| 20 | 2011 | 47 |
About Michael Weig
Michael Weig is a scholar working on Infectious Diseases, Clinical Biochemistry, Epidemiology, Molecular Biology and Food Science, having authored 74 papers that have together received 3k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (38 papers), Fungal and yeast genetics research (14 papers), Bacterial Identification and Susceptibility Testing (11 papers), Fungal Infections and Studies (8 papers), Salmonella and Campylobacter epidemiology (5 papers), Antibiotic Resistance in Bacteria (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and SARS-CoV-2 detection and testing (2 papers). The work is most often cited by research in Infectious Diseases (1.7k citations), Clinical Biochemistry (288 citations), Molecular Medicine (81 citations), Molecular Biology (665 citations) and Epidemiology (274 citations). Michael Weig has collaborated with scholars based in Germany, United Kingdom and Netherlands. Frequent co-authors include Oliver Bader, Uwe Groß, Piet W. J. de Groot, Raimond Lugert, Albert D. de Boer, Martin Kuhns, Diane E Kelly, Andrew G. S. Warrilow, Steven L. Kelly and Neeraj Chauhan. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Mycoses, PLoS ONE, Journal of Clinical Microbiology and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.